Lilly says Zepbound cut health costs in older adults (LLY:NYSE)
· seekingalpha.com
Eli Lilly (LLY) says long-term use of its blockbuster weight loss therapy Zepbound was linked to lower healthcare costs over time in older adults. Read more here.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...